Prescription drug · ANDA
Allopurinol NDC 71335-9676
Allopurinol 300 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-9676-1 | 71335967601 | 30 TABLET in 1 BOTTLE (71335-9676-1)Marketed from Jul 8, 2024 | |
| 71335-9676-2 | 71335967602 | 60 TABLET in 1 BOTTLE (71335-9676-2)Marketed from Apr 13, 2026 | |
| 71335-9676-3 | 71335967603 | 100 TABLET in 1 BOTTLE (71335-9676-3)Marketed from Mar 13, 2024 | |
| 71335-9676-4 | 71335967604 | 90 TABLET in 1 BOTTLE (71335-9676-4)Marketed from Apr 19, 2023 | |
| 71335-9676-5 | 71335967605 | 20 TABLET in 1 BOTTLE (71335-9676-5)Marketed from Apr 13, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Allopurinol
- Generic name (nonproprietary)
- allopurinol
- Active ingredients
- Allopurinol — 300 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 018659
- Marketing start
- Listing expires
- Other FDA classes
- Xanthine Oxidase Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-9676_86e949b9-8bbb-4553-94b9-a269765d7d65SPL ID 86e949b9-8bbb-4553-94b9-a269765d7d65SPL set ID 5dca2d4f-0e93-4d1a-8d9f-b9b72867c242RxCUI 197320UNII 63CZ7GJN5I
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335967601followed by a unit qualifier and the quantityPackage 71335-9676-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Allopurinol tablets are indicated for: • The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) • The management of adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels • The management of adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients, despite lifestyle changes (such as reduction of dietary sodium, non-dairy animal protein, oxalate rich foods, refined sugars…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 018659
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-186 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Coupler LLC | 67046-0681 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-0282 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Safecor Health, LLC | 48433-002 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Safecor Health, LLC | 48433-003 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-5454 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Cardinal Health 107, LLC | 55154-5534 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-0137 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Mylan Institutional Inc. | 51079-206 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Mylan Institutional Inc. | 51079-205 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 0378-0181 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0383 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8424 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4412 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 67544-736 |